Monitoring R&D activities
This section brings together data from global data sources that allow health R&D activities to be monitored, with a description of the scope and limitations for each set of data.
Tableau software was used for the analysis, allowing interactive and user customized data visualization and examination. Sources used for these analyses are described in the Databases section, under Databases and resources.
The Analyses and syntheses section of the Observatory draws on these data and other available disease-specific evidence (e.g. from reports) to discuss them in comprehensive reviews.
Monitoring of R&D activities is organized under the three categories below.
Inputs to R&D
Funding flows for health R&D by disease
Product related health R&D for neglected diseases (G-FINDER)
- by disease, year and funding category
- by country, funder, recipient organizations and other breakdown
- by source and type of funding
Funding flows for health R&D by country
Grants for health research by major funders
Grants for biomedical research (World RePORT) - NEW UPDATE!
Outputs for R&D
Publication of research
Processes for R&D
Pipeline analyses
- Health products in the pipeline from discovery to market launch for all diseases
- Clinical trials on monoclonal antibodies
- Human genomics in clinical studies
Antimicrobial products
- Antibacterial products in clinical development
- Antibacterial products in preclinical development
- Antifungal preclinical and clinical pipeline review NEW
- Trends in antibacterial products in clinical development, 2017 to current
- Bacterial vaccines in development for drug-resistant pathogens
Vector borne diseases
Neglected Tropical Diseases
Cancer
Publications
Human genomics technologies in clinical studies – the research landscape: report on the 1990-2024 period
Genomic technologies are becoming increasingly central to clinical practice, with the potential to transform the way diseases are diagnosed, treated and...
Despite significant progress in therapeutic development, cancer is still associated with a substantial global disease burden, which is projected...
Clinical research landscape of monoclonal antibodies
Monoclonal antibodies (mAbs) are artificial proteins that mimic the body’s natural defences and represent an important medical innovation in modern...
Paediatric research and development landscape for neglected tropical diseases: Report on 1999–2022 period
Neglected tropical diseases (NTDs) are a diverse set of 21 diseases and disease groups that mainly affect resource-poor populations in tropical and subtropical...
Funding landscape for research on health, migration and displacement: report for 2016-2020 period
Migrants, refugees and other displaced populations are often excluded from research and evidence generation and from public health interventions and policies....
This report provides an overview of the funding and R&D landscape in childhood cancer. The report, based on data from the WHO Global Observatory on...